Description
Clinical Description
LUMI-PN FACE is a polynucleotide (PDRN) skin-booster product, formulated with ultra-pure polydeoxyribonucleotides (PDRN) at a concentration of 20 mg/ml, delivering a total of 50 mg per 2.5 ml syringe. Rather than acting as a volumising filler, its mechanism is regenerative: PDRN fragments are claimed to support skin tissue repair, stimulate fibroblast activity, promote extracellular matrix remodelling, and improve skin hydration, tone, elasticity and overall skin quality. The formulation targets skin rejuvenation rather than structural volume augmentation, making it suitable for skin that is dull, dehydrated, thin, or showing early signs of ageing.
What LUMI-PN FACE Is Similar To
LUMI-PN FACE belongs to the class of regenerative skin boosters (like polynucleotide or PDRN boosters) rather than traditional hyaluronic acid (HA) fillers. For orientation, it is similar in purpose to treatments such as Profhilo — which aim to improve skin hydration, elasticity, and quality rather than volumising — although Profhilo uses high-concentration HA rather than PDRN. Unlike HA fillers (which add volume and define contours), LUMI-PN FACE focuses on skin regeneration, collagen/elastin support and improving skin texture and tone. Compared with simpler mesotherapy or superficial boosters (vitamins, low-dose HA), LUMI-PN FACE provides a higher polynucleotide load per treatment, targeting deeper regenerative effects. This comparison is provided for clinical orientation only and does not imply interchangeability.
Treatment Areas / Indications
According to available manufacturer/distributor information, LUMI-PN FACE is suitable for: face, neck, décolletage, and hands.
If other zones are used (e.g., under-eye, periocular, scarred areas) — these are not explicitly specified.
Usage / Administration (IFU-only)
-
Injection depth / method: Not clearly specified in publicly available documentation. Several distributors list the product under “microneedling / mesotherapy / skin booster” categories rather than classical dermal fillers.
-
Volume per point / injection site: Not provided by manufacturer.
-
Needle gauge / tool: Not provided by manufacturer. Some sources indicate use with microneedling devices or mesotherapy needles rather than large-gauge filler needles.
-
Frequency / number of sessions: Not provided by manufacturer; common industry practice (not official) is a course of several sessions spaced a few weeks apart.
-
Professional-use disclaimer: Product intended for use by qualified aesthetic practitioners under aseptic conditions.
Because public documentation does not describe a standard IFU specifying depth, needle, or protocol, any mention of serial-puncture, microneedling or injection technique derives from how some clinics offer the product — not from a verified IFU.
Ingredient List
-
Polynucleotides (PDRN) 20 mg/ml (total 50 mg per 2.5 ml syringe)
-
Water (Aqua) as base solvent.
-
Sodium DNA / Sodium Chloride / Phosphate salts (buffer components) — listed in one retailer’s ingredient specification.
-
No hyaluronic acid, lidocaine, or cross-linked gel is declared — thus, no volumising carrier matrix is indicated.
Presentation & Longevity
-
Packaging: 1 × 2.5 ml pre-filled syringe.
-
Shelf life / expiry: Not provided in publicly available documentation.
-
Treatment duration: Because the product is regenerative rather than volumising, “longevity” is not defined as a lasting filling effect. The effect depends on skin renewal and patient-specific factors; a fixed duration is not provided by manufacturer.
Safety Notes / Contraindications
Public sources do not provide a full IFU-based list of contraindications. Based on standard practice for skin-boosting or PDRN treatments, and on disclaimers by distributors:
-
Should be administered only by qualified professionals under aseptic conditions.
-
Use is contraindicated in patients with active skin infection, inflammation, or open wounds at the target site (standard caution for injectables / mesotherapy) — though not explicitly stated, this is general good practice.
-
Allergic or hypersensitivity reactions possible: as with any biologically derived product, origins of PDRN should be considered; patients with sensitivity should be assessed individually.
-
Not recommended for self-administration.
Regulatory Status
-
The product is sold in the UK market. However, none of the publicly accessible retailer pages clearly state a CE-mark, UKCA marking, or registration status. For example, the product description pages for UK distributors list “Polynucleotide Skin Booster” without regulatory labelling.
Regulatory classification not specified in public documentation; verify on the product pack or manufacturer’s IFU.
FAQ
Q1: What exactly is PDRN, and how does LUMI-PN FACE act on the skin?
A1: PDRN (polydeoxyribonucleotide) are fragments of DNA derived from purified sources; when applied to the skin (via injection or mesotherapy), they are believed to support cellular repair, stimulate fibroblast activity, and encourage extracellular matrix regeneration. LUMI-PN FACE delivers 50 mg of ultra-pure PDRN per syringe, aiming to promote skin repair, improved hydration, elasticity, and overall skin quality rather than volumising.
Q2: Will LUMI-PN FACE add volume like a dermal filler?
A2: No — LUMI-PN FACE is not designed as a volumising filler. It does not contain hyaluronic acid gel or cross-linked HA; its base is an aqueous PDRN solution. The purpose is skin rejuvenation, hydration and regeneration, not structural contouring or volume augmentation.
Q3: Which treatment areas can be addressed with LUMI-PN FACE?
A3: According to distributor information, LUMI-PN FACE can be used on the face, neck, décolletage and hands. Additional use on other zones or delicate areas (e.g., peri-ocular) is not explicitly confirmed in public documentation.
Q4: What is the recommended administration method and treatment schedule?
A4: The official public sources do not provide a detailed injection protocol (depth, needle gauge, number of sessions, volume per point). Only that it is marketed under “skin booster / microneedling / mesotherapy” treatments.Therefore, administration and treatment planning must rely on practitioner judgement, local standards, and a licensed IFU.
Q5: Can LUMI-PN FACE be regarded as a safe regenerative alternative to fillers?
A5: When administered by qualified professionals under aseptic conditions, PDRN-based skin boosters like LUMI-PN FACE offer a non-volumising approach focused on skin quality, hydration, and tissue regeneration — which may carry lower risk of overfilling or unnatural contour changes compared with volumising fillers. However, because robust publicly accessible clinical trial data or regulatory documentation is limited, practitioners should exercise caution, inform patients clearly, and monitor outcomes carefully.
